Skip to content

Leadership

Bo Cumbo

President
and Chief Executive Officer

Jessie Hanrahan, PhD

Chief Regulatory Officer

Paul Herzich

Chief Technology Officer

Ty Howton

Chief Operating Officer
and Legal Counsel

Jenny Marlowe, PhD

Chief Scientific Officer

Douglas Swirsky

Chief Financial Officer

Christopher Wright, MD, PhD

Chief Medical Officer

Board of Directors

Barry Byrne, MD, PhD

– Founder

Manuela Corti, PT, PhD

– Founder

Bo Cumbo

– CEO

Ellen Hukkelhoven, PhD

Benjamin Lund

Jake Simson, PhD

Ian Smith

Scientific Founders

Barry Byrne,

MD, PhD

Manuela Corti,

PT, PhD

2014

A mother whose son lives with Friedreich’s ataxia approached Dr Byrne and Dr Corti about working on Friedreich’s ataxia

2015

The mother raised $30K through a community fundraiser to initiate a pilot research program at the University of Florida

2016

Dr Byrne and Dr Corti were awarded a grant from GoFAR to fund their preclinical work

2017

AavantiBio was founded

2019

The pivotal translation into clinical trials was supported by funding from MDA Venture Philanthropy

2020

Management team and syndicate were formed; Series A financing was completed in October to support future growth

Strategic Partnerships